Al-Debasi, T., Al-Bekairy, A., Al-Katheri, A., Al Harbi, S., & Mansour, M. (2017). Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization. Saudi J Ophthalmol.

Al-Debasi, Tariq, Abdulkareem Al-Bekairy, Abdulmalik Al-Katheri, Shmeylan Al Harbi, ja Mahmoud Mansour. "Topical Versus Subconjunctival Anti-vascular Endothelial Growth Factor Therapy (Bevacizumab, Ranibizumab and Aflibercept) for Treatment of Corneal Neovascularization." Saudi J Ophthalmol 2017.

Al-Debasi, Tariq, et al. "Topical Versus Subconjunctival Anti-vascular Endothelial Growth Factor Therapy (Bevacizumab, Ranibizumab and Aflibercept) for Treatment of Corneal Neovascularization." Saudi J Ophthalmol 2017.